I’m excited to share my executive biography, reflecting my journey in biomedical engineering, healthcare innovation, medical devices, diagnostics, entrepreneurship, and technology commercialization. Throughout my career, I have been passionate about transforming scientific discoveries into practical healthcare solutions while building partnerships that accelerate innovation and improve patient outcomes. I look forward to continuing to contribute through board service, strategic advisory roles, and collaborations that shape the future of healthcare.

Ross Bundy is a pioneering biotechnology leader driving innovation in biosensor technology and genome editing optimization. As the CEO of CRISPR QC and co-founder of Cardea Bio Inc., he has been instrumental in developing platforms that enable real-time biological insights through the "Internet of Biology." With expertise in business development, financial strategy, and operational management, Bundy has successfully scaled multiple companies and forged key industry partnerships. His visionary leadership and strategic execution continue to shape the future of biotechnology, advancing diagnostics, therapeutics, and bioinformatics with cutting-edge solutions.